GMC1877-shutterstock_1799586823-IN-SHAPE.png

Prepare the wound bed

Prepare the wound bed

Target early excision as the gold standard for reducing the intensity of hypermetabolism and removing the biological environment for infection, thereby reducing the risk of sepsis.2

Accelerate your surgical debridement*3-5

Explore the VERSAJET II Hydrosurgery System as a powerful surgical tool to help:

  • Provide a smoother, more regular and consistent wound bed (ready to receive a skin graft)*6

  • Disrupt and remove biofilm from contaminated tissue, helping to prevent bacteria or biofilm from reforming and causing localised infection**7

  • Precisely and safely debride burned necrotic tissue (superficial and intermediate depth)8 and other unwanted material from the wound surface, and help preserve viable tissue.9,10

Burns website - VERSAJET II - 750x1000 - 72pp
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book. It has survived not only five centuries, but also the leap into electronic typesetting, remaining essentially unchanged. It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum. It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using 'Content here, content here', making it look like readable English. Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for 'lorem ipsum' will uncover many web sites still in their infancy. Various versions have evolved over the years, sometimes by accident, sometimes on purpose (injected humour and the like). 

Contrary to popular belief, Lorem Ipsum is not simply random text. It has roots in a piece of classical Latin literature from 45 BC, making it over 2000 years old. Richard McClintock, a Latin professor at Hampden-Sydney College in Virginia, looked up one of the more obscure Latin words, consectetur, from a Lorem Ipsum passage, and going through the cites of the word in classical literature, discovered the undoubtable source. Lorem Ipsum comes from sections 1.10.32 and 1.10.33 of "de Finibus Bonorum et Malorum" (The Extremes of Good and Evil) by Cicero, written in 45 BC. This book is a treatise on the theory of ethics, very popular during the Renaissance. The first line of Lorem Ipsum, "Lorem ipsum dolor sit amet..", comes from a line in section 1.10.32.

The standard chunk of Lorem Ipsum used since the 1500s is reproduced below for those interested. Sections 1.10.32 and 1.10.33 from "de Finibus Bonorum et Malorum" by Cicero are also reproduced in their exact original form, accompanied by English versions from the 1914 translation by H. Rackham.  

Protecting from infection

Protect from infection

Consider the use of a topical antimicrobial to help slow the process of sepsis; shown to be instrumental in preventing larger, more severe burns from succumbing to sepsis.2

Fast and effective protection11-14

Use ACTICOAT Antimicrobial Barrier Dressings to help minimise the risk of infection in paediatric and adult patients.

  • Fast-acting to kill bacteria in as little as 30 minutes***15-20

  • Effective against a broad spectrum of bacterial and fungal wound pathogens***15,16,21,22

  • Conformable to anatomical areas and help minimise trauma to the wound on dressing removal26,27 23,24


Rehydrate tissue

Use INTRASITEGel and INTRASITE Conformable Hydrogel Wound Dressings in conjunction with ACTICOAT Dressings.

Burns website - INTRASITE - ACTICOAT - 1000x1000 - 72pp

Solutions for protection

Progress to healing

Progress to healing

Support re-epithelialisation with the use of temporary skin substitutes2 and consider the use of tradition or single-use negative pressure wound therapy (NPWT).

Choose a suitable pathway

  • For extensive body surface areas: BIOBRANE Temporary Biosynthetic Wound Dressings are easy to apply25-29 and conform to surfaces to allow joint movement.28,30 Suitable for paediatric patients,28,31,32 they may require a limited number of dressing changes compared to standard care33,34

  • To help prepare for healing or grafting: The RENASYS Negative Pressure Wound Therapy System with foam or gauze may help promote the formation of granulation tissue,35-37 remove exudate and promote moisture balance35,38-41

  • For portable, single-use NPWT: The portable PICO Negative Pressure Wound Therapy System provides up to 7 or 14 days of NPWT, protecting the wound from external contamination41 and facilitating successful skin grafting41,43

Burns website BIOBRANE - PICO - RENASYS - 1000x827 - 72pp


Products

Medical Education

See all the other courses we have
No results.


Related products

Disclaimers

*Compared to sharp debridement.

**As demonstrated in vivo.

***As demonstrated in vitro.

Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Smith+Nephew representative or distributor if you have questions about the availability of Smith+Nephew products in your area. For detailed product information, including indications for use, contraindications, precautions and warnings, please consult the product’s applicable Instructions for Use (IFU) prior to use.

Citations

1.Burns. World Health Organization. Updated March 6th, 2018. Accessed March 17th, 2023. https://www.who.int/news-room/fact-sheets/detail/burns#:~:text=An%20estimated%20180%20000%20deaths,in%20the%20home%20and%20workplace
2. Marc G. Jeschke, et al. Nat Rev Dis Primers. 2020 Feb 13;6(1):11.
3. Caputo WJ, et al. Int Wound J. 2008;5(2):288–294.
4. Liu J, et al. Int Wound J. 2015;12(4):456–461.
5. McAleer JP, Kaplan EM, Perisich G, Axman W. A Prospective Randomized Study Evaluating the Time Efficiency of the VERSAJET™ Hydrosurgery System and Traditional Wound Debridement. Poster presented at: ACFAS 2005; New Orleans, LA.
6. Vanwiljck R, et al. J Plast, Reconstr & Aesthetic Surg. 2010;63:544–549.
7. Allan N. In Abstracts 20th Meeting of the European Tissue Repair Society, 2010; 9, 77–98.
8. Rennekampff HA, et al. Burns. 2006;32(1):64–69.
9. Hyland EJ, et al. Burns. 2015;41(4):700–707.
10. Matsumura H,. Annal Plast Surg. 2012;69(5):521–525.
11. Gago M,. Wounds. 2008;20(10):273–278.
12. Tredget EE, et al. J Burn Care Rehabil. 1998;19(6):531–537.
13. Strohal R, et al. J Hosp Infect. 2005;60(3):226–230.
14. Chaloner D, et al. A comparative study of two silver containing dressings, ACTICOAT 7 and Avance, in the treatment of chronic venous ulcers. Poster presented at: WUWHS2004; Paris.
15. Wright JB, et al. Am J Infect Control. 1998;26(6):572–577.
16. Wright JB, et al. Am J Infect Control. 1999;27(4):344–350.
17. Smith+Nephew 2008.. Internal Report. DOF 0810018.
18. Smith+Nephew 2008.. Internal Report. DOF 0810014.
19. Yin HQ, et al. J Burn Care Rehabil. 1999;20(3):195–200.
20. Wright JB, et al. Wounds. 1998;10(6):179–188.
21. Smith+Nephew 2008. Internal Report. DOF 0810016.
22. Smith+Nephew 2008. Internal Report. DOF 0810012. 23
23. Smith+Nephew 2011. Internal Report. SR/CE/036/ACB. 26
24. Smith+Nephew 2011. Internal Report. SR/CIME/017. 27

25. Erdman D, et al. Burns. 1996;22(2):141–146.

26. Lo CH, et al. J Plast Reconstr Aesthet Surg. 2019;72(3):427–437.
27. Muganza A, et al.. Glob J Med Res. 2014;14(6):5–12.
28. Lesher AP, et al. J Pediatr Surg. 2011;46(9):1759–1763.
29. Austin RE, et al. Burns. 2015;41(4):749–753.
30. Farroha A, et al. Ann Burns Fire Disasters. 2013;XXVI(2):94–97.
31. Muganza A, et al. Glob J Med Res. 2014;14(6):5–12.
32. Cassidy C, et al. Burns. 2005;31(7):890–893.
33. Lang EM, et al. Ann Plast Surg. 2005;55(5):485–489.
34. Lal S, Barrow RE, et al. Shock (Augusta, Ga). 2000;14(3):314–318; 318–319.
35. Dunn R, et al. Int J Surg. 2011;9(3):258–262.
36. Chan SYC, et al. Diabet Foot Ankle. 2014;17(5):1–7.
37. Young SR, Hampton S, Martin R. Int Wound J. 2013;10(4):383-388. 
41 Forle M, et al. A randomised controlled trial to compare the clinical efficacy and acceptability of adjustable intermittent and continuous Negative Pressure Wound Therapy (NPWT) in a new portable NPWT system. Poster presented at: European Wound Management Association (EWMA)2018.
42. Birke-Sorensen H, et al. J Plast Reconstr Aesthet Surg. 2011;64(1):S1–S16.
43. Young SR, et al. Int Wound J. 2013;10(4):383–388.
44. Canonico S, et al. Acta Vulnol. 2012;10(2):57–66.
45. Smith+Nephew 2020. Internal Report. 2001002.
46. Hudson DA, et al. Int Wound J. 2015;12(2):195–201.

Title

Text